P. Pivettipezzi et al., OCULAR MANIFESTATIONS IN HIV-RELATED LYMPHOMA PATIENTS - INFLUENCE OFLYMPHOMA AND RELATED TREATMENT, Annals of ophthalmology. Glaucoma, 28(4), 1996, pp. 227-234
Twenty-one consecutive HIV-related lymphoma patients were ophthalmolog
ically observed (mean follow-up, 24.9 months) to evaluate the incidenc
e of ocular involvement. Six of 21 patients already had AIDS at lympho
ma diagnosis and received a moderate lymphoma treatment, whereas 12 of
the other 15 were intensively treated. No statistical difference betw
een HIV-related lymphoma patients and 40 HIV-positive control group pa
tients (same clinical status; mean ophthalmologic followup, 18.9 month
s) was found concerning the incidence of HIV-related retinal microangi
opathy (P, 0.9), cytomegalovirus retinitis, and toxoplasmic retinochor
oiditis (P, 1, respectively). Nevertheless, in HIV-related lymphoma pa
tients all the opportunistic ocular infections were found in those who
already had AIDS at lymphoma diagnosis, with a statistical significan
t difference (P, 0.0158; odds ratio, 14.29). No differences were detec
ted in the two groups of patients concerning the clinical course of th
e opportunistic ocular infections. It was concluded that (1) the prese
nce of lymphoma per se has a marginal influence on the development and
clinical course of opportunistic ocular infections; (2) the incidence
of these infections in HIV-associated lymphoma patients is mostly rel
ated to the grade of immunodeficiency that preceded lymphoma diagnosis
; (3) the lymphoma treatment may increase the risk of opportunistic oc
ular infections only in patients who had full-blown AIDS before the ap
pearance of lymphoma, whereas it appears to have no influence even if
it is administered intensively in HIV patients without severe immunode
ficiency before lymphoma diagnosis.